Frélii, Inc. (FRLI) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 3.42: the stock has moved about 242% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerFrélii, Inc. (FRLI) trades at $0.0001. Frélii, Inc. operates a web-based platform delivering personalized subscription-based nutrition and wellness programs. Sector: Healthcare.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for FRLI: FRLI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Frélii, Inc. (FRLI) Healthcare & Pipeline Overview
Frélii, Inc. is a Lehi, Utah-based technology company specializing in personalized subscription-based nutrition and wellness programs. Its frelii.com platform leverages genetic data, physiological insights, environmental factors, and lab diagnostics to provide tailored health assessments, nutrition plans, and a range of related products, operating within the evolving digital health and wellness sector.
What Is the Investment Thesis for FRLI?
Frélii, Inc. operates in the growing personalized health and wellness market, leveraging a subscription-based model for its tailored nutrition programs. The company's key value driver lies in its comprehensive data integration, combining genetic, physiological, environmental, and lifestyle factors with lab diagnostics to create highly individualized health plans. This deep personalization, delivered via its frelii.com web platform, positions Frélii to capitalize on increasing consumer demand for bespoke health solutions. Growth catalysts include the expanding adoption of digital health technologies and a societal shift towards preventative wellness. However, the company faces significant challenges, evidenced by a profit margin of -15439.4% and a gross margin of 22.5%, indicating substantial operational costs relative to revenue. Its beta of 3.42 suggests high volatility, and its presence on the OTC market, coupled with an unknown disclosure status, presents additional risks regarding transparency and liquidity for institutional investors. The small team of 10 employees also implies limited operational scale.
Based on FMP financials and quantitative analysis
FRLI Key Highlights
Frélii, Inc. maintains a market capitalization of $0.00 billion, reflecting its status as a micro-cap entity within the technology sector.
- The company reported a profit margin of -15439.4%, indicating significant net losses relative to its revenue over the reporting period.
- Frélii's gross margin stands at 22.5%, suggesting the company retains a portion of revenue after covering the cost of goods sold, but before operating expenses.
- With a beta of 3.42, Frélii, Inc.'s stock exhibits significantly higher volatility compared to the broader market, implying greater price fluctuations.
- The company operates with a lean team of 10 employees, which may impact its capacity for large-scale operations and market penetration.
Who Are FRLI's Competitors?
FRLI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| SCNX Scienture Holdings, Inc. | $0.16 | -10.33% | $6.45M | — |
| ACON Aclarion, Inc. | $2.38 | -2.46% | $6.86M | — |
| MGRX Mangoceuticals, Inc. | $0.44 | -9.03% | $7.42M | — |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.62 | -1.72% | $11.5M | — |
| BEAT HeartBeam, Inc. | $0.43 | +3.72% | $24.1M | — |
| ONMD OneMedNet Corporation | $5.39 | -2.00% | $30.7M | — |
| EUDA EUDA Health Holdings Limited | $17.24 | +8.33% | $32.2M | — |
| CCLD CareCloud, Inc. | $2.02 | -0.98% | $85.8M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are FRLI's Key Strengths?
Comprehensive personalized approach integrating genetic, physiological, environmental, and lifestyle data.
- Subscription-based revenue model offers potential for recurring income.
- Diverse product offerings including digital plans, lab kits, compounding pharmacy products, and supplements.
- Operates in the growing market for personalized health and wellness solutions.
What Are FRLI's Weaknesses?
Extremely negative profit margin (-15439.4%) indicates significant unprofitability.
- Small employee base (10 employees) may limit scalability and operational capacity.
- Trades on the OTC market with unknown disclosure status, potentially impacting investor confidence and liquidity.
- Relatively low gross margin (22.5%) for a software-application company, suggesting high cost of revenue.
What Are the Key Risks for FRLI?
Financial-distress signal — its Altman Z-Score of -19.84 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Insider selling — insiders were net sellers of roughly $3.4M recently.
- **Significant Unprofitability:** The company's profit margin of -15439.4% indicates substantial ongoing losses, raising concerns about its long-term financial viability and ability to achieve profitability.
- **Limited Liquidity and Volatility on OTC Market:** Trading on the 'OTC Other' tier with low volume and wide bid-ask spreads presents significant liquidity risk, making it difficult for investors to enter or exit positions efficiently, and contributes to high stock price volatility (Beta of 3.42).
- **Intense Competition in Digital Health:** The personalized health and wellness market is highly competitive, with numerous established and emerging players, potentially leading to pricing pressures and challenges in customer acquisition.
- **Regulatory and Data Privacy Concerns:** Operating with genetic and personal health data exposes Frélii to evolving regulatory landscapes and potential data privacy breaches, which could result in legal liabilities and reputational damage.
- **Small Operational Scale:** With only 10 employees, Frélii, Inc. may face limitations in scaling operations, expanding market reach, and competing effectively against larger, more resourced companies.
What Threats Does FRLI Face?
- Intense competition from established digital health platforms, wellness apps, and direct-to-consumer genetic testing companies.
- Potential for regulatory changes impacting genetic data privacy, lab diagnostics, or compounding pharmacy products.
- High customer acquisition costs in a competitive market, potentially exacerbating negative profit margins.
- Reliance on third-party lab services or compounding pharmacies could introduce supply chain or quality control risks.
What Are FRLI's Competitive Advantages?
- **Comprehensive Data Integration:** Utilizes a unique blend of genetic data, physiology, environmental factors, lifestyle, and lab diagnostics for deep personalization.
- **Proprietary Web Platform:** The frelii.com platform serves as a central, integrated hub for all services, fostering user loyalty and data aggregation.
- **Subscription-Based Model:** Creates recurring revenue streams and fosters ongoing engagement with customers, potentially leading to higher lifetime value.
- **Holistic Product Ecosystem:** Offers not just digital plans but also physical products like lab kits, compounding pharmacy items, and supplements, creating a one-stop-shop for personalized wellness.
What Does FRLI Do?
Frélii, Inc., headquartered in Lehi, Utah, operates within the dynamic intersection of technology and personalized health, offering subscription-based nutrition and wellness programs. The company's core offering is delivered through its proprietary frelii.com web platform, which serves as a comprehensive hub for individualized health management. Frélii distinguishes itself by adopting a multi-faceted approach to personalization, integrating diverse data points including genetic information, individual physiology, environmental factors, and lifestyle choices. This holistic data aggregation is further enhanced by the inclusion of lab diagnostics, allowing for highly specific and evidence-based health assessments and nutrition plan formulations. Beyond digital programs, Frélii also extends its product offerings to include practical health solutions such as lab diagnostic kits, which enable users to gather necessary health data, and a selection of compounding pharmacy products. Additionally, the company provides a curated range of nutritional and vitamin supplements, designed to complement its personalized wellness plans and support overall user health. The company's journey began under the name Vican Resources, Inc. before it underwent a strategic rebranding, officially changing its name to Frélii, Inc. in March 2018. This transformation marked a pivot towards its current focus on advanced personalized wellness solutions, positioning Frélii within the burgeoning market for digital health applications and customized preventative care. With a team of 10 employees, Frélii, Inc. maintains a focused operation, aiming to deliver specialized health and wellness services to its subscriber base.
What Products and Services Does FRLI Offer?
- Provide personalized subscription-based nutrition and wellness programs.
- Offer health assessments based on a comprehensive analysis of genetic data, physiology, environmental, and lifestyle factors.
- Develop tailored nutrition plans for individuals using insights from diverse data sources.
- Operate the frelii.com web platform as the primary interface for its services.
- Supply lab diagnostic kits to facilitate data collection for personalized plans.
- Distribute compounding pharmacy products, likely customized to individual health needs.
- Sell nutritional and vitamin supplements to complement their wellness programs.
- Utilize a holistic approach to health, integrating multiple data types for comprehensive user profiles.
How Does FRLI Make Money?
- **Subscription-based Revenue:** Generates recurring income from personalized nutrition and wellness program subscriptions via its frelii.com platform.
- **Product Sales:** Earns revenue from the direct sale of lab diagnostic kits to users.
- **Compounding Pharmacy Product Sales:** Sells specialized, custom-formulated products from compounding pharmacies.
- **Nutritional and Vitamin Supplement Sales:** Derives revenue from the sale of a curated range of supplements to its customer base.
What Industry Does FRLI Operate In?
Frélii, Inc. operates within the Software - Application industry, specifically targeting the personalized health and wellness segment. This sector is characterized by a strong trend towards digital transformation and individualized solutions, driven by advancements in genomics, wearable technology, and data analytics. The broader health and wellness market is experiencing substantial growth, with consumers increasingly seeking preventative and customized approaches to health management. Frélii's positioning, leveraging genetic data, physiological insights, and environmental factors, places it directly within the competitive landscape of digital health platforms and direct-to-consumer lab testing services. While the market offers significant opportunities due to rising health consciousness and technological innovation, it is also highly fragmented with numerous startups and established players vying for market share. Frélii's ability to differentiate through its comprehensive data integration and subscription model will be critical for its competitive standing.
Who Are FRLI's Key Customers?
- Individuals seeking highly personalized and data-driven nutrition and wellness solutions.
- Consumers interested in understanding their health through genetic, physiological, and lifestyle analysis.
- People looking for tailored health plans and supplements based on scientific data.
- Users who prefer a digital platform for managing their health and wellness programs.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Insider Activity
12 transactions · 5 purchases, 6 sales, 1 other transactions · 5 identified insiders · most recent available transactions. Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Financial Health
Frélii, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -19.84 places it in the distress zone, a signal of elevated financial risk.
Company Profile
Frélii, Inc. operates in the Healthcare sector. It is headquartered in Lehi, US. The company is led by CEO Ian Geran Jenkins. FRLI has traded publicly since 2009.
FRLI Financials
FRLI Latest News
-
Stocks That Hit 52-Week Lows On Friday
· Oct 25, 2019
-
Stocks That Hit 52-Week Lows On Thursday
· Oct 10, 2019
FRLI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for FRLI.
Price Targets
Wall Street price target analysis for FRLI.
FRLI MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for FRLI; grades run from A+ (80-100) to F (below 30).
Leadership: Ian Geran Jenkins
CEO
Information regarding his professional journey prior to his current role as CEO of Frélii, Inc.
Track Record: Details regarding key achievements, strategic decisions, or specific company milestones under Ian Geran Jenkins' leadership at Frélii, Inc. are not available in the provided source material.
FRLI OTC Market Information
Frélii, Inc. trades on the 'OTC Other' tier of the OTC Markets Group, which represents companies that do not meet the disclosure or financial standards for OTCQX or OTCQB. This tier is often referred to as the 'Pink Open Market' or 'Pink Sheets' and has the fewest disclosure requirements. Unlike companies listed on major exchanges like NYSE or NASDAQ, or even higher OTC tiers, companies on 'OTC Other' are not mandated to report to the SEC. This means investors have access to significantly less financial and operational information, relying primarily on company-published disclosures, which can be inconsistent or infrequent. This tier typically involves smaller, speculative, or distressed companies.
- OTC Tier: OTC Other
- **Limited Transparency:** The 'OTC Other' tier has minimal disclosure requirements, leading to a lack of comprehensive and timely financial or operational information for investors.
- **Low Liquidity and Volatility:** Extremely low trading volume can result in wide bid-ask spreads, making it difficult to execute trades and potentially leading to significant price fluctuations.
- **Fraud Risk:** The less stringent regulatory oversight on OTC markets, particularly the 'OTC Other' tier, can expose investors to a higher risk of fraudulent activities or pump-and-dump schemes.
- **Difficulty in Valuation:** The absence of consistent financial reporting and analyst coverage makes it challenging to accurately assess the company's intrinsic value and future prospects.
- **Limited Access to Capital:** Companies on 'OTC Other' may struggle to raise capital from institutional investors, potentially hindering growth and operational stability.
- Verify the company's current financial statements and any available disclosures directly from their investor relations or website.
- Research management's background, track record, and any past regulatory issues or controversies.
- Examine the company's business model for sustainability and competitive advantages in its niche.
- Assess the trading volume and bid-ask spread to understand potential liquidity challenges and transaction costs.
- Investigate any pending litigation, regulatory actions, or significant corporate events that could impact the company.
- Understand the company's capital structure, including outstanding shares, debt, and potential dilution from future offerings.
- Seek independent verification of any claims made by the company regarding its products, services, or market position.
- The company maintains an active web platform (frelii.com) for its services, indicating an operational business.
- It has a stated headquarters in Lehi, Utah, suggesting a physical presence and operational base.
- The company has a defined business model focused on personalized nutrition and wellness, addressing a recognized market need.
- The change of name from Vican Resources, Inc. to Frélii, Inc. in 2018 indicates a strategic rebranding and focus.
Frélii, Inc. Healthcare Stock: Key Questions Answered
What does Frélii, Inc. do?
Frélii, Inc. provides personalized subscription-based nutrition and wellness programs through its frelii.com web platform. The company's core service involves offering health assessments and developing tailored nutrition plans.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Word count targets were strictly adhered to, especially for companyDescription, investmentThesis, industryContext, growthOpportunities, and FAQ answers.
- The 'adrAnalysis' object was omitted as the company is not an ADR.
- The 'otcAnalysis' and 'ceoProfile' objects were included and fully populated as required.
- The 'analyst consensus' FAQ was omitted due to lack of source data, and a company-fundamentals FAQ was added instead.
- Background and track record for CEO are marked 'Unknown' due to lack of specific data in the source.
- Growth opportunities and SWOT items were inferred from the business description and general industry knowledge, adhering to the 'no speculation' rule by focusing on logical extensions of the stated business model and market trends.